PTX:ASX
Prescient Therapeutics Ltd
A$0,055
0,00%
(0,00) 1D
20 Nov., 16:00:00 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0,06
High
A$0,06
Low
A$0,06
Mkt. cap
62,91Â m.
Avg. vol.
417,00Â k
Volume
259,60Â k
52-wk high
A$0,12
52-wk low
A$0,05
EPS
-A$0,01
Shares outstanding
1,14Â mjd.
No. of employees
3
Open
A$0,06
High
A$0,06
Low
A$0,06
Mkt. cap
62,91Â m.
Avg. vol.
417,00Â k
Volume
259,60Â k
52-wk high
A$0,12
52-wk low
A$0,05
EPS
-A$0,01
Shares outstanding
1,14Â mjd.
No. of employees
3
News stories
From web sources and news partners
Yahoo Finance
·
5 uur gelede
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
24/7 Wall St.
·
7 uur gelede
The S&P 500 Is Now Below Every Wall Street Year-End Target for 2026
WSJ
·
1 dag gelede
Dow, S&P 500 Poised to Close at a Correction
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded22 Mei 1986
Headquarters-
SectorHealth Care
Industry-
Websiteptxtherapeutics.com